loadpatents
name:-0.009401798248291
name:-0.024209976196289
name:-0.00051116943359375
Bohlen; Peter Patent Filings

Bohlen; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bohlen; Peter.The latest application filed is for "antibodies against vascular endothelial growth factor receptor-1".

Company Profile
0.22.7
  • Bohlen; Peter - New York NY
  • Bohlen; Peter - Peekskill NY
  • Bohlen; Peter - Cortland Manor NY
  • Bohlen; Peter - Cortlandt NY
  • Bohlen; Peter - Cortland NY
  • Bohlen; Peter - Ulster CH
  • Bohlen; Peter - San Diego CA
  • Bohlen; Peter - Encinitas CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies against vascular endothelial growth factor receptor-1
Grant 8,143,025 - Wu , et al. March 27, 2
2012-03-27
Antibodies Against Vascular Endothelial Growth Factor Receptor-1
App 20110269186 - WU; Yan ;   et al.
2011-11-03
Antibodies against vascular endothelial growth factor receptor-1
Grant 7,972,596 - Wu , et al. July 5, 2
2011-07-05
Antibodies Against Vascular Endothelial Growth Factor Receptor-1
App 20100028347 - Wu; Yan ;   et al.
2010-02-04
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability
App 20090060909 - LIAO; Fang ;   et al.
2009-03-05
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability
App 20080317750 - LIAO; Fang ;   et al.
2008-12-25
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability
App 20080311121 - Liao; Fang ;   et al.
2008-12-18
Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
Grant 7,371,574 - Liao , et al. May 13, 2
2008-05-13
Method and composition for inhibiting heparanase activity
App 20040247577 - Bohlen, Peter ;   et al.
2004-12-09
Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
App 20020160003 - Liao, Fang ;   et al.
2002-10-31
Stabilization of fibroblast growth factors by modification of cysteine residues
Grant 6,010,999 - Daley , et al. January 4, 2
2000-01-04
Stabilization of somatotropins and other proteins by modification of cysteine residues
Grant 5,951,972 - Daley , et al. September 14, 1
1999-09-14
Methods for inhibiting proliferation of tumor cells and tumor growth
Grant 5,856,315 - Backer , et al. January 5, 1
1999-01-05
Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
Grant 5,843,925 - Backer , et al. December 1, 1
1998-12-01
Therapeutic compositions and methods for use of heparin-binding brain mitogens
Grant 5,641,743 - Bohlen , et al. June 24, 1
1997-06-24
Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth
Grant 5,574,026 - Backer , et al. November 12, 1
1996-11-12
Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
Grant 5,567,693 - Backer , et al. October 22, 1
1996-10-22
Bovine basic fibroblast growth factor
Grant 5,464,774 - Baird , et al. November 7, 1
1995-11-07
Active fragments of fibroblast growth factor
Grant 5,387,673 - Seddon , et al. February 7, 1
1995-02-07
Chimeric fibroblast growth factors
Grant 5,310,883 - Seddon , et al. May 10, 1
1994-05-10
Human MK gene and method of expression
Grant 5,210,026 - Kovesdi , et al. May 11, 1
1993-05-11
Heparin-binding brain mitogens
Grant 5,171,842 - Bohlen , et al. December 15, 1
1992-12-15
Basic fibroblast growth factor
Grant 5,155,214 - Baird , et al. * October 13, 1
1992-10-13
Isolation of fibroblast growth factor
Grant 4,785,079 - Gospodarowicz , et al. November 15, 1
1988-11-15
Purification of T-cell growth factor
Grant 4,675,383 - Bohlen , et al. June 23, 1
1987-06-23
Ovine GRF
Grant 4,605,643 - Bohlen , et al. August 12, 1
1986-08-12
Bovine GRF
Grant 4,585,756 - Brazeau, Jr. , et al. April 29, 1
1986-04-29
Mammalian PGRF
Grant 4,517,181 - Ling , et al. May 14, 1
1985-05-14
Extended N-terminal somatostatin
Grant 4,316,891 - Guillemin , et al. February 23, 1
1982-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed